-
1
-
-
0031741034
-
Urine drug testing for social service agencies: A Canadian experience
-
Fraser A.D. Urine drug testing for social service agencies: a Canadian experience. Clin. Lab. Med. 18:1988;705-711
-
(1988)
Clin. Lab. Med.
, vol.18
, pp. 705-711
-
-
Fraser, A.D.1
-
2
-
-
0035479338
-
A six year experience with urine drug testing by family service agencies in Nova Scotia, Canada
-
Fraser A.D. A six year experience with urine drug testing by family service agencies in Nova Scotia, Canada. Forensic Science International. 121:2001;151-156
-
(2001)
Forensic Science International
, vol.121
, pp. 151-156
-
-
Fraser, A.D.1
-
4
-
-
0023920115
-
Confirmation of marijuana, cocaine, morphine, codeine, amphetamine, methamphetamine, phencyclidine by GC/MS in urine following immunoassay screening
-
Mule S.J., Casella G.A. Confirmation of marijuana, cocaine, morphine, codeine, amphetamine, methamphetamine, phencyclidine by GC/MS in urine following immunoassay screening. J. Anal. Toxicol. 12:1988;102-110
-
(1988)
J. Anal. Toxicol.
, vol.12
, pp. 102-110
-
-
Mule, S.J.1
Casella, G.A.2
-
5
-
-
0026316892
-
Importance of creatinine analysis of urine when screening for abused drugs
-
Lafolie P., Beck O., Blennow G. Importance of creatinine analysis of urine when screening for abused drugs. Clin. Chem. 37:1991;1927-1933
-
(1991)
Clin. Chem.
, vol.37
, pp. 1927-1933
-
-
Lafolie, P.1
Beck, O.2
Blennow, G.3
-
6
-
-
0030627156
-
Comparison of self-reported drug use with quantitative and qualitative urinalysis of drug use in treatment studies
-
Preston K.L., Silverman K., Schuster C.R., Cone E.J. Comparison of self-reported drug use with quantitative and qualitative urinalysis of drug use in treatment studies. Natl. Inst. Drug Abuse Monogr. 167:1997;130-145
-
(1997)
Natl. Inst. Drug Abuse Monogr.
, vol.167
, pp. 130-145
-
-
Preston, K.L.1
Silverman, K.2
Schuster, C.R.3
Cone, E.J.4
-
8
-
-
0029121975
-
Detection times of marijuana metabolites in urine by immunoassay and GC-MS
-
Huestis M.A., Mitchell J.M., Cone E.J. Detection times of marijuana metabolites in urine by immunoassay and GC-MS. J. Anal. Toxicol. 19:1995;443-449
-
(1995)
J. Anal. Toxicol.
, vol.19
, pp. 443-449
-
-
Huestis, M.A.1
Mitchell, J.M.2
Cone, E.J.3
-
9
-
-
0031666368
-
Differentiating new marijuana use from residual drug excretion in occasional marijuana users
-
Huestis M.A., Cone E.J. Differentiating new marijuana use from residual drug excretion in occasional marijuana users. J. Anal. Toxicol. 22:1998;445-454
-
(1998)
J. Anal. Toxicol.
, vol.22
, pp. 445-454
-
-
Huestis, M.A.1
Cone, E.J.2
-
10
-
-
0002247082
-
® dau™ cannabinoid urine assay for substance abuse treatment
-
S. Agurell, W. L. Dewy, R. Willette (Eds.), Academic Press, New York
-
® dau™ cannabinoid urine assay for substance abuse treatment, in: S. Agurell, W. L. Dewy, R. Willette (Eds.), The Cannabinoids: Chemical, Pharmacologic and Therapeutic Aspects, Academic Press, New York, 1984, pp. 281-290.
-
(1984)
The Cannabinoids: Chemical, Pharmacologic and Therapeutic Aspects
, pp. 281-290
-
-
Manno, J.E.1
Ferslew, K.E.2
Manno, B.R.3
-
13
-
-
0034785653
-
9-tetrahydrocannabinol-9-carboxylic acid
-
9-tetrahydrocannabinol-9- carboxylic acid. J. Anal. Toxicol. 25:2001;538-548
-
(2001)
J. Anal. Toxicol.
, vol.25
, pp. 538-548
-
-
Manno, J.E.1
Manno, B.R.2
Kemp, P.M.3
Alford, D.D.4
Abukhalaf, I.K.5
McWilliams, M.E.6
Hagaman, F.N.7
Fitzgerald, M.J.8
|